175 related articles for article (PubMed ID: 36913175)
1. CYP2C19 gene polymorphism in Ningxia.
Yang Z; Xie Y; Zhang D; Zou Y; Li X; Chen R; Zhang X; Chen S; Bai F
Pharmacol Rep; 2023 Jun; 75(3):705-714. PubMed ID: 36913175
[TBL] [Abstract][Full Text] [Related]
2. Distribution of CYP2C19, ABCB1 and PON1 polymorphisms in Chinese Han, Hui, Uygur and Kazak patients with coronary atherosclerotic heart disease.
Ma L; Yuan Y; Li J; Yu C; Zhao J
Int J Immunogenet; 2020 Dec; 47(6):539-545. PubMed ID: 32862511
[TBL] [Abstract][Full Text] [Related]
3. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.
Yin SJ; Ni YB; Wang SM; Wang X; Lou YQ; Zhang GL
J Clin Pharm Ther; 2012 Jun; 37(3):364-9. PubMed ID: 21913948
[TBL] [Abstract][Full Text] [Related]
4. Influence of CYP2C19 on Helicobacter pylori eradication in Brazilian patients with functional dyspepsia.
Nabinger DD; Mazzoleni LE; Sander GB; Mazzoleni F; Osório MC; Klein MG; Rech TF; Basso da Silva L; de Moraes GS; Cristovam RA; Nardelli EF; Francesconi CF; Simon D
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706745
[TBL] [Abstract][Full Text] [Related]
5. CYP2C19 Genotype, CagA Genotype and Antibiotic Resistant Strain of Helicobacter pylori Infection.
Auttajaroon J; Chotivitayatarakorn P; Yamaoka Y; Vilaichone RK
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1243-1247. PubMed ID: 31030500
[TBL] [Abstract][Full Text] [Related]
6. CYP2C19, PON1, and ABCB1 gene polymorphisms in Han and Uygur populations with coronary artery disease in Northwestern Xinjiang, China, From 2014 Through 2019.
Wang T; Zhao T; Bao S; Jia L; Feng J; Yu A; Sun L; Guo X; Li H; Yu L
Medicine (Baltimore); 2020 Jul; 99(29):e20582. PubMed ID: 32702814
[TBL] [Abstract][Full Text] [Related]
7. Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer.
Jainan W; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(24):10957-60. PubMed ID: 25605208
[TBL] [Abstract][Full Text] [Related]
8. [Association of CYP2C19 and CYP3A5 gene polymorphisms with myocardial infarction].
Qi L; Liang W; Qiao H; Wang R; Han J; Xing X; Hu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jan; 38(1):87-91. PubMed ID: 33423267
[TBL] [Abstract][Full Text] [Related]
9. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.
Zuo LJ; Guo T; Xia DY; Jia LH
Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the CYP2C19 genetic polymorphism in Han and Uyghur patients with cardiovascular and cerebrovascular diseases in the Kashi area of Xinjiang.
Li Y; Yang H; Zou X; Xiong L; Li Z; Luo J; Zhao B; Liu W; Du X
Med Sci Monit; 2014 Nov; 20():2213-8. PubMed ID: 25381554
[TBL] [Abstract][Full Text] [Related]
11. CYP2C19*2 polymorphism in Polish peptic ulcer patients.
Sałagacka-Kubiak A; Żebrowska-Nawrocka M; Jeleń A; Mirowski M; Balcerczak E
Pharmacol Rep; 2019 Apr; 71(2):272-275. PubMed ID: 30826566
[TBL] [Abstract][Full Text] [Related]
12. Gastric Juice-Based Real-Time PCR for Tailored
Peng X; Song Z; He L; Lin S; Gong Y; Sun L; Zhao F; Gu Y; You Y; Zhou L; Zhang J
Int J Med Sci; 2017; 14(6):595-601. PubMed ID: 28638276
[TBL] [Abstract][Full Text] [Related]
13. CYP2C19-rs4986893 confers risk to major depressive disorder and bipolar disorder in the Han Chinese population whereas ABCB1-rs1045642 acts as a protective factor.
Zhang T; Rao Q; Lin K; He Y; Cai J; Yang M; Xu Y; Hou L; Lin Y; Liu H
BMC Psychiatry; 2023 Jan; 23(1):69. PubMed ID: 36698099
[TBL] [Abstract][Full Text] [Related]
14. Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication.
Karaca RO; Kalkisim S; Altinbas A; Kilincalp S; Yuksel I; Goktas MT; Yasar U; Bozkurt A; Babaoglu MO
Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):199-206. PubMed ID: 27611887
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy.
Ram M R; Teh X; Rajakumar T; Goh KL; Leow AHR; Poh BH; Mariappan V; Shankar EM; Loke MF; Vadivelu J
J Antimicrob Chemother; 2019 Jan; 74(1):11-16. PubMed ID: 30403784
[TBL] [Abstract][Full Text] [Related]
16. CYP2C19 polymorphism influences Helicobacter pylori eradication.
Kuo CH; Lu CY; Shih HY; Liu CJ; Wu MC; Hu HM; Hsu WH; Yu FJ; Wu DC; Kuo FC
World J Gastroenterol; 2014 Nov; 20(43):16029-36. PubMed ID: 25473155
[TBL] [Abstract][Full Text] [Related]
17. Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole.
Ormeci A; Emrence Z; Baran B; Gokturk S; Soyer OM; Evirgen S; Akyuz F; Karaca C; Besisik F; Kaymakoglu S; Ustek D; Demir K
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):879-85. PubMed ID: 27010145
[TBL] [Abstract][Full Text] [Related]
18. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
Oh JH; Dong MS; Choi MG; Yoo HW; Lee SB; Park YI; Chung IS
J Gastroenterol Hepatol; 2009 Feb; 24(2):294-8. PubMed ID: 18823430
[TBL] [Abstract][Full Text] [Related]
19. Microarray-Based Detection and Clinical Evaluation for
Song Y; Dou F; Zhou Z; Yang N; Zhong J; Pan J; Liu Q; Zhang J; Wang S
Biomed Res Int; 2018; 2018():2684836. PubMed ID: 30276203
[No Abstract] [Full Text] [Related]
20. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection.
Sugimoto M; Furuta T; Shirai N; Nakamura A; Kajimura M; Sugimura H; Hishida A; Ishizaki T
Aliment Pharmacol Ther; 2005 Nov; 22(10):1033-40. PubMed ID: 16268979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
